Antenatal steroids: can we optimize the dose?

被引:31
|
作者
Romejko-Wolniewicz, Ewa [1 ]
Teliga-Czajkowska, Justyna [2 ]
Czajkowski, Krzysztof [1 ]
机构
[1] Med Univ Warsaw, Dept Obstet & Gynecol 2, PL-00315 Warsaw, Poland
[2] Med Univ Warsaw, Dept Didact Gynecol & Obstet, PL-00315 Warsaw, Poland
关键词
antenatal steroids; dosage regimen; preterm delivery; RESPIRATORY-DISTRESS-SYNDROME; STRESS PHYSIOLOGY; CORTICOSTEROIDS; BETAMETHASONE; EXPOSURE; INFANTS; WOMEN; GLUCOCORTICOIDS; EXPRESSION; THERAPY;
D O I
10.1097/GCO.0000000000000047
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of reviewThe beneficial effects of antenatal steroids in women at risk of preterm birth are evident. A dose of 24mg appears sufficient, but there are insufficient data to recommend betamethasone or dexamethasone, a single steroid dose, the optimal interval between doses and repeated courses, the gestational age at which treatment is beneficial and the long-term effects of steroid treatment. This review addresses these aspects of antenatal steroid treatment.Recent findingsAlthough the 12-h and 24-h dosing intervals are equivalent with respect to prevention of respiratory distress syndrome, the former enables the completion of treatment in 50% more neonates delivered prematurely. Reducing the single steroid dose in patients at risk for premature birth reduces the associated maternal side effects. An inverse relationship has been demonstrated between the number of corticosteroid courses and foetal growth. The reduced size of exposed foetuses has been attributed to birth at earlier gestational ages and decreased foetal growth. Evidence suggests that antenatal exposure to synthetic glucocorticoids in term-born children has long-lasting effects, which may have important implications in the recommendation of steroids before elective caesarean at term.SummaryThe short-term and long-term effects of the dosage regimen on the pregnant mother and foetus remain unclear.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [1] Antenatal steroids and the developing brain
    Whitelaw, A
    Thoresen, M
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2000, 83 (02): : F154 - F157
  • [2] Antenatal Late Preterm Steroids: The Evolution of the ALPS Trial
    Gyamfi-Bannerman, Cynthia
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2024, 67 (02) : 399 - 410
  • [3] Timing of antenatal steroids exposure and its effects on neonates
    Lau, Hester C. Q.
    Tung, Janice S. Z.
    Wong, Tiffany T. C.
    Tan, P. L.
    Tagore, Shephali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 296 (06) : 1091 - 1096
  • [4] Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth
    Mwansa-Kambafwile, Judith
    Cousens, Simon
    Hansen, Thomas
    Lawn, Joy E.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2010, 39 : 122 - 133
  • [5] Antenatal steroids-Not always and not repeatedly
    Buehrer, Christoph
    GYNAKOLOGIE, 2024, 57 (06): : 411 - 417
  • [6] Controversy: Antenatal Steroids
    Wapner, Ronald
    Jobe, Alan H.
    CLINICS IN PERINATOLOGY, 2011, 38 (03) : 529 - +
  • [7] Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis
    Been, J. V.
    Degraeuwe, P. L.
    Kramer, B. W.
    Zimmermann, L. J. I.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (02) : 113 - 122
  • [8] Antenatal Corticosteroids in the Management of Preterm Birth: Are We Back Where We Started?
    Bonanno, Clarissa
    Wapner, Ronald J.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2012, 39 (01) : 47 - +
  • [9] Is Biology Destiny or Can We Optimize Care for All Patients?
    Douglas, Pamela S.
    Curtis, Lesley H.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (03) : 241 - U106
  • [10] Antenatal Late Preterm Steroids (ALPS): are we ready to accept it?
    Kamatkar, S.
    Jobe, A.
    JOURNAL OF PERINATOLOGY, 2017, 37 (06) : 624 - 625